772
Views
0
CrossRef citations to date
0
Altmetric
PUBLIC MENTAL HEALTH

Childhood adversity and co-dependency roles in a case of a midwife with pethidine use disorder attending Mulago National Referral Hospital, Kampala, Uganda

ORCID Icon, , &
Article: 2145704 | Received 17 Mar 2021, Accepted 04 Nov 2022, Published online: 17 Nov 2022

References

  • Al-Maaz, S., Abu-Dahab, R., Shawagfeh, M., & Wazaify, M. (2019). Prevalence and pattern of substance use and misuse among anesthesia health-care personnel in Jordan. Journal of Substance Use, 24(3), 317–7. https://doi.org/10.1080/14659891.2019.1570366
  • Annagür, B. B. (2012, March 1). A nurse with pethidine addiction. European Journal of General Medicine, 9(1). https://doi.org/10.29333/ejgm/82557
  • Barlow, O. W., & Lewis, J. R. (1951, Oct). Toxicology and addiction liability of meperidine (demerol) in experimental animals. The Journal of Pharmacology and Experimental Therapeutics, 103(2), 147–152. PMID: 14881077.
  • Bateman, C. (2004, September). The drug-addicted doctor–who dares to care? South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde, 94(9), 726–727. PMID: 15487828.
  • Batterman, R. C., & Mulholland, J. H. (1943). DEMEROL: A SUBSTITUTE FOR MORPHINE IN THE TREATMENT OF POSTOPERATIVE PAIN. Archives of Surgery, 46(3), 404–409. https://doi.org/10.1001/archsurg.1943.01220090099008
  • Benjet, C., Borges, G., Medina-Mora, M. E., & Méndez, E. (2013, July 1). Chronic childhood adversity and stages of substance use involvement in adolescents. Drug and Alcohol Dependence, 131(1–2), 85–91. https://doi.org/10.1016/j.drugalcdep.2012.12.002. Epub 2012 Dec 29. PMID: 23276477.
  • Buck, M. L. (2011, July). Is meperidine the drug that just won’t die? The Journal of Pediatric Pharmacology and Therapeutics: JPPT: the Official Journal of PPAG, 16(3), 167–169. https://doi.org/10.5863/1551-6776-16.3.167. PMID: 22479158; PMCID: PMC3292527.
  • Carr, D. B., & Jacox, A. K. (1997). Acute pain management: Operative or medical procedures and trauma clinical practice guideline. DIANE Publishing.
  • Enoch, M.-A., Hodgkinson, C. A., Yuan, Q., Shen, P.-H., Goldman, D., & Roy, A. (2010, January 1). The influence of GABRA2, childhood trauma, and their interaction on alcohol, heroin, and cocaine dependence. Biological Psychiatry, 67(1), 20–27. https://doi.org/10.1016/j.biopsych.2009.08.019. PMID: 19833324; PMCID: PMC2964936.
  • Harkness, D., & Cotrell, G. (1997, Sep-Oct). The social construction of co-dependency in the treatment of substance abuse. Journal of Substance Abuse Treatment, 14(5), 473–479. https://doi.org/10.1016/s0740-5472(97)00121-9. PMID: 9437617.
  • Hung, C. I., Liu, C. Y., Chen, C. Y., Yang, C. H., & Yeh, E. K. (2001, Jan-February). Meperidine addiction or treatment frustration? General Hospital Psychiatry, 23(1), 31–35. https://doi.org/10.1016/s0163-8343(00)00105-5. PMID: 11226555.
  • ICCE. (2015). The universal treatment curriculum for substance use disorders. Physiology and Pharmacology for Addiction Professionals, 148–158. https://www.issup.net/training/universal-treatment-curriculum
  • Ives, T. J., Chelminski, P. R., Hammett-Stabler, C. A., Malone, R. M., Perhac, J. S., Potisek, N. M., Shilliday, B. B., DeWalt, D. A., & Pignone, M. P. (2006, April 4). Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Services Research, 6(1), 46. https://doi.org/10.1186/1472-6963-6-46. PMID: 16595013; PMCID: PMC1513222.
  • Izenwasser, S., Newman, A. H., Cox, B. M., & Katz, J. L. (1996, February 15). The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter. European Journal of Pharmacology, 297(1–2), 9–17. https://doi.org/10.1016/0014-2999(95)00696-6. PMID: 8851160.
  • Kessler, R. C., McLaughlin, K. A., Green, J. G., Gruber, M. J., Sampson, N. A., Zaslavsky, A. M., Aguilar-Gaxiola, S., Alhamzawi, A. O., Alonso, J., Angermeyer, M., Benjet, C., Bromet, E., Chatterji, S., de Girolamo, G., Demyttenaere, K., Fayyad, J., Florescu, S., Gal, G., Gureje, O., and Williams, D. R. (2010, November). Childhood adversities and adult psychopathology in the WHO world mental health surveys. British Journal of Psychiatry, 197(5), 378–385. https://doi.org/10.1192/bjp.bp.110.080499. PMID: 21037215; PMCID: PMC2966503.
  • Kul, A., Ozdemir, M., & Sagirli, O. (2020, July 15). Determination of pethidine of abuse and relevant metabolite norpethidine in urine by ultra-performance liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 186, 113320. https://doi.org/10.1016/j.jpba.2020.113320. Epub 2020 Apr 23. PMID: 32387748.
  • Latta, K. S., Ginsberg, B., & Barkin, R. L. (2002, Jan-February). Meperidine: A critical review. American Journal of Therapeutics, 9(1), 53–68. https://doi.org/10.1097/00045391-200201000-00010. PMID: 11782820.
  • Mpewo, J. T. (2019). Healthcare workers perspectives of controlled prescription drug abuse in the health care workforce at Mulago National and Jinja Regional Referral hospitals. Makerere University.
  • Özer, Ü., Sever, A., Çetin, T., & Evren, C. (2010). Venlafaxine pharmacotherapy in meperidine addiction and chronic pain comorbidity: A case report. Dusunen Adam the Journal of Psychiatry and Neurological Sciences, 1(23), 69–72. https://doi.org/10.5350/DAJPN2010230111t
  • Von Eisleb, O., & Schaumann, O. (1939). Dolantin, ein neuartiges spasmolytickum und analgetikum. DMW - Deutsche Medizinische Wochenschrift, 55(24), 967–968. https://doi.org/10.1055/s-0028-1120563
  • Wang, T., Ma, J., Wang, R., Liu, Z., Shi, J., Lu, L., & Bao, Y. (2018, June 7). poly-drug use of prescription medicine among people with opioid use disorder in china: A systematic review and meta-analysis. Substance Use & Misuse, 53(7), 1117–1127. https://doi.org/10.1080/10826084.2017.1400066. Epub 2017 Dec 27. PMID: 29281497.